Impaired replication stress response in cells from immunodeficiency patients carrying cernunnos/XLF mutations

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Schwartz, Michal ^a   Oren, Yifat S ^a   Bester, Assaf C ^a   Rahat, Ayelet ^a   Sfez, Ruthy ^a   Yitzchaik, Shlomo ^a   de Villartay, Jean Pierre ^b,c,d   Kerem, Batsheva ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CERNUNNOS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRESS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; GENE MUTATION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY;

EID: 84887212606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004516     Document Type: Article

References (55)

1. Wyman C, Kanaar R (2006) DNA double-strand break repair: all's well that ends well. Annu Rev Genet 40: 363-383.
2. Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23: 687-696.
3. Burma S, Chen BP, Chen DJ (2006) Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 5: 1042-1048.
4. Hefferin ML, Tomkinson AE (2005) Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst) 4: 639-648.
5. Buck D, Malivert L, de Chasseval R, Barraud A, Fondaneche MC, et al. (2006) Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124: 287-299.
6. Ahnesorg P, Smith P, Jackson SP (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313.
7. Lu H, Pannicke U, Schwarz K, Lieber MR (2007) Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity. J Biol Chem 282: 11155-11162.
8. Tsai CJ, Kim SA, Chu G (2007) Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc Natl Acad Sci U S A 104: 7851-7856.
9. Zha S, Alt FW, Cheng HL, Brush JW, Li G (2007) Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proc Natl Acad Sci U S A 104: 4518-4523.
10. Dai Y, Kysela B, Hanakahi LA, Manolis K, Riballo E, et al. (2003) Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci U S A 100: 2462-2467.
11. Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S (2006) Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair (Amst) 5: 1021-1029.
12. Saintigny Y, Delacote F, Vares G, Petitot F, Lambert S, et al. (2001) Characterization of homologous recombination induced by replication inhibition in mammalian cells. Embo J 20: 3861-3870.
13. Lundin C, Erixon K, Arnaudeau C, Schultz N, Jenssen D, et al. (2002) Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells. Mol Cell Biol 22: 5869-5878.
14. Arnaudeau C, Lundin C, Helleday T (2001) DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 307: 1235-1245.
15. Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, et al. (2005) Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev 19: 2715-2726.
16. Richards RI (2001) Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 17: 339-345.
17. Arlt MF, Casper AM, Glover TW (2003) Common fragile sites. Cytogenet Genome Res 100: 92-100.
18. Cheng CH, Kuchta RD (1993) DNA polymerase epsilon: aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry 32: 8568-8574.
19. Ikegami S, Taguchi T, Ohashi M, Oguro M, Nagano H, et al. (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature 275: 458-460.
20. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
21. Rogakou EP, Boon C, Redon C, Bonner WM (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146: 905-916.
22. Ward IM, Chen J (2001) Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 276: 47759-47762.
23. Rothkamm K, Lobrich M (2003) Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 100: 5057-5062.
24. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429.
25. Durkin SG, Arlt MF, Howlett NG, Glover TW (2006) Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25: 4381-4388.
26. Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67: 136-142.
27. Ozeri-Galai E, Schwartz M, Rahat A, Kerem B (2008) Interplay between ATM and ATR in the regulation of common fragile site stability. Oncogene 27: 2109-2117.
28. Pirzio LM, Pichierri P, Bignami M, Franchitto A (2008) Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol 180: 305-314.
29. Durkin SG, Glover TW (2007) Chromosome fragile sites. Annu Rev Genet 41: 169-192.
30. Casper AM, Durkin SG, Arlt MF, Glover TW (2004) Chromosomal instability at common fragile sites in seckel syndrome. Am J Hum Genet 75: 654-660.
31. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet.
32. Daboussi F, Courbet S, Benhamou S, Kannouche P, Zdzienicka MZ, et al. (2008) A homologous recombination defect affects replication-fork progression in mammalian cells. J Cell Sci 121: 162-166.
33. Herrick J, Bensimon A (1999) Single molecule analysis of DNA replication. Biochimie 81: 859-871.
34. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, et al. (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
35. Moshous D, Pannetier C, Chasseval RdR, Deist FlF, Cavazzana-Calvo M, et al. (2003) Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 111: 381-387.
36. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, et al. (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8: 1175-1185.
37. Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA (1999) Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 9: 699-702.
38. Riballo E, Doherty AJ, Dai Y, Stiff T, Oettinger MA, Jeggo PA, Kysela B (2001) Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem 276: 31124-31132.
39. Shimura T, Martin MM, Torres MJ, Gu C, Pluth JM, et al. (2007) DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication. J Mol Biol 367: 665-680.
40. Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, et al. (2006) Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 209: 883-893.
41. Difilippantonio M, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T, Nussenzweig A (2000) DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404: 510-514.
42. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW (2000) Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897-900.
43. Sharpless N, Ferguson DO, OHagan RC, Castrillon DH, Lee C, Farazi PA, Alson S, Fleming J, Morton CC, Frank K, Chin L, Alt FW, DePinho RA (2001) Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell 8: 1187-1196.
44. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, et al. (1998) DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152: 1107-1123.
45. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, et al. (1999) DNA copy number losses in human neoplasms. Am J Pathol 155: 683-694.
46. Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, et al. (2008) Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29: 381-389.
47. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, et al. (2003) Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446.
48. Bau DT, Fu YP, Chen ST, Cheng TC, Yu JC, et al. (2004) Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous endjoining genes are affected by BRCA1. Cancer Res 64: 5013-5019.
49. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
50. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
51. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
52. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
53. Allen C, Kurimasa A, Brenneman MA, Chen DJ, Nickoloff JA (2002) DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination. Proc Natl Acad Sci U S A 99: 3758-3763.
54. Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC (1988) Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet 80: 224-234.
55. Michalet X, Ekong R, Fougerousse F, Rousseaux S, Schurra C, et al. (1997) Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science 277: 1518-1523.